Europäischer CBD- & Hanf-Rechtshub

The EU Framework: What Applies Everywhere

At the European Union level, industrial hemp cultivation is governed by Regulation (EU) 2021/2115, which sets the maximum THC content for eligible hemp varieties at 0.3% in the standing crop as of 2023. However, member states retain the authority to impose stricter limits, and several — including France and Sweden — have maintained tighter national thresholds.

The Novel Food Regulation (EU) 2015/2283 is the single most significant regulatory framework for CBD products sold as food supplements. Under this regulation, any food ingredient not consumed to a significant degree within the EU before May 1997 requires pre-market safety authorisation from the European Food Safety Authority (EFSA). The European Commission determined in 2019 that CBD extracts qualify as novel foods. As of 2026, EFSA's evaluation remains ongoing, with data gaps identified relating to liver effects, drug interactions, and reproductive toxicity.

The Cosmetics Regulation (EC) 1223/2009 applies to CBD used in topical products, creams, and balms. Directive 2001/83/EC governs CBD when developed as a medicinal product. The 2020 Kanavape ruling (Case C-663/18) by the Court of Justice of the European Union established that member states may not prohibit the marketing of CBD lawfully produced in another member state when extracted from the Cannabis sativa plant in its entirety.

The Kanavape Ruling and Why It Matters

The 2020 Kanavape ruling (Case C-663/18) is the most significant judicial decision affecting the European CBD market. French authorities had prosecuted the sellers of a CBD vape product called Kanavape, arguing that CBD extracted from the whole hemp plant — not just fibre and seeds — was prohibited under French law. The case was referred to the Court of Justice of the European Union (CJEU), which ruled that member states may not prohibit the marketing of CBD lawfully produced in another member state.

The CJEU based its ruling on the principle of free movement of goods within the EU single market. If a product is lawfully manufactured in one member state — as CBD is in countries like the Czech Republic and Germany — other member states cannot simply ban its sale. The court also determined that CBD is not a narcotic drug under the 1961 UN Single Convention, a finding with significant implications beyond the immediate case. This ruling effectively forced countries like France to open their markets to CBD products, though they have done so with varying degrees of enthusiasm and continued restrictions.

However, the Kanavape ruling has limits. It does not override national novel food enforcement, does not harmonise THC limits across member states, and does not prevent member states from regulating CBD product categories — food, cosmetics, vapes, flowers — through their own national legislation. It establishes that a blanket ban on CBD products from other member states is unlawful, but it leaves plenty of room for national regulation within those bounds.

THC Limits: What the Numbers Actually Mean

A common misconception among CBD consumers is that a single THC percentage — typically 0.2% or 0.3% — defines legality across Europe. In practice, THC regulation involves multiple layers: the cultivation limit for the standing crop, the limit for raw hemp material, the limit for extracts and intermediates, and the limit for finished consumer products. These limits may all differ, and enforcement authorities may apply them differently depending on product category and intended use.

Most commercially available EU-compliant CBD products target a maximum of 0.2% THC in the finished product, because this ensures compliance across all member states regardless of national variations. Heffernan's Hemp tests every production batch to verify THC content below 0.2% by independent ISO/IEC 17025-accredited laboratory analysis. This conservative approach means our products are suitable for shipping to most European countries where CBD is legal.

For consumers in countries with zero-THC or non-detectable THC requirements — notably Sweden, and to some extent the Netherlands — full-spectrum products may not be appropriate, regardless of how low the THC content is. In these markets, broad-spectrum or isolate products should be considered, understanding the trade-off in therapeutic efficacy due to the reduced entourage effect.

Country-Specific Deep Dives

We maintain detailed, individual country guides for 17 European countries, covering THC limits, product category rules, market conditions, full-spectrum considerations, product cautions, shopper advice, and local context. Each guide includes practical buying checklists and links to official regulatory sources. Select your country from the comparison tool below or browse the complete country directory.

These country guides are reviewed quarterly to reflect regulatory changes, new court rulings, and evolving enforcement practice. CBD law is not static — the European market has changed dramatically since 2019, and it continues to evolve. Always verify current rules before ordering, importing, or travelling with CBD products.

Is CBD legal everywhere in Europe?

No. CBD rules vary significantly by country, product type, THC content, and intended use. While the EU single market and the Kanavape ruling have harmonised some aspects, individual member states maintain their own regulatory frameworks and enforcement practices. Always check the rules in your specific country before ordering.

What is the EU THC limit for CBD products?

There is no single EU-wide THC limit for finished CBD products. The cultivation limit for industrial hemp is 0.3% THC in the standing crop under Regulation (EU) 2021/2115. Finished product limits vary by country, with most commercially compliant products targeting ≤0.2% THC to ensure cross-market compatibility.

Can I travel with CBD between EU countries?

Travelling with CBD across borders carries risk, because the product legal in your departure country may not be legal at your destination or in any country you transit through. Carry lab reports, keep products in original packaging, check every country on your route, and consider not travelling with full-spectrum products if any country on your itinerary has strict THC rules.

What did the Kanavape ruling change?

The 2020 Kanavape ruling (CJEU Case C-663/18) established that EU member states cannot prohibit the sale of CBD products lawfully manufactured in another member state, and that CBD is not a narcotic under international drug conventions. This forced countries like France to open their markets, though national regulation continues.